Hoong Caroline Wei Shan, Broski Stephen M, Sfeir Jad G, Clarke Bart Lyman
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic Rochester, Rochester, MN 55905, United States.
Department of Endocrinology, Woodlands Health, National Healthcare Group, 737628, Singapore.
JBMR Plus. 2024 May 31;8(7):ziae074. doi: 10.1093/jbmrpl/ziae074. eCollection 2024 Jul.
Normocalcemic hyperparathyroidism (NHPT) is variably defined, and information regarding complications and natural history are scarce. We aimed to describe the phenotype of NHPT in relation to hypercalcemic hyperparathyroidism (PHPT) and controls, to determine risk of progression, and to develop a predictive model for progression to PHPT. This is a retrospective chart review of 232 patients at a tertiary medical center, comparing 75 controls, 73 patients with NHPT, and 84 with PHPT. NHPT was intermediate in biochemical profile between controls and PHPT with respect to cCa, iPTH, intraindividual coefficient of variant of cCa, phosphorus, and 25(OH)D. NHPT patients had an increased adjusted risk of urolithiasis (OR 5.34, 95%CI, 2.41-12.71, < .001) and fragility fractures (OR 4.53, 95%CI, 1.63-14.84, = .006) versus controls, after adjustment for age, sex, and BMI. Fewer NHPT compared with PHPTH patients achieved cure with parathyroidectomy ( = .001). NHPT more often had nonlocalizing imaging or polyglandular disease ( = .005). Parathyroidectomy improved biochemical but not BMD parameters in NHPT. Over a median follow-up of 4.23 (IQR 1.76-5.31) years, NHPT patients managed expectantly experienced no change in iPTH, and progression to PHPT occurred in 9%. An XGBoost model combining 6 factors for progression (mean index 2 iPTH, mean index 2 cCa, 24-h urinary calcium, age, 25(OH)D, and presence of urolithiasis) had an area under the curve 1.00 (95%CI, 1.00-1.00, < .001) for predicting combined progression. NHPT is a mild variant of PHPT at intermediate risk of urolithiasis and fragility fractures. Cure was less often achieved with parathyroidectomy, which did not improve BMD parameters. Progression was infrequent with conservative management. Because only a minority progressed to PHPT, in addition to lower surgical success rates, we suggest conservative management for the majority of NHPT unless risk factors for progression are identified.
血钙正常的甲状旁腺功能亢进症(NHPT)的定义尚不统一,关于其并发症和自然病史的信息也很匮乏。我们旨在描述NHPT相对于高钙血症性甲状旁腺功能亢进症(PHPT)及对照组的表型,确定其进展风险,并建立一个预测进展为PHPT的模型。这是一项对某三级医疗中心232例患者的回顾性病历审查,比较了75名对照组、73例NHPT患者和84例PHPT患者。就校正钙(cCa)、离子化甲状旁腺激素(iPTH)、cCa个体内变异系数、磷和25羟维生素D而言,NHPT的生化特征介于对照组和PHPT之间。在校正年龄、性别和体重指数后,与对照组相比,NHPT患者发生尿路结石的校正风险增加(比值比5.34,95%置信区间2.41 - 12.71,P < 0.001),发生脆性骨折的风险增加(比值比4.53,95%置信区间1.63 - 14.84,P = 0.006)。与PHPT患者相比,接受甲状旁腺切除术后治愈的NHPT患者更少(P = 0.001)。NHPT更常出现非定位性影像学表现或多腺体疾病(P = 0.005)。甲状旁腺切除术改善了NHPT患者的生化指标,但未改善骨密度参数。在中位随访4.23(四分位间距1.76 - 5.31)年期间,接受保守治疗的NHPT患者iPTH无变化,9%进展为PHPT。一个结合了6个进展因素(平均指数2的iPTH、平均指数2的cCa、24小时尿钙、年龄、25羟维生素D和尿路结石的存在)的XGBoost模型预测联合进展的曲线下面积为1.00(95%置信区间1.00 - 1.00,P < 0.001)。NHPT是PHPT的一种轻度变异型,有发生尿路结石和脆性骨折的中度风险。甲状旁腺切除术后治愈的情况较少,且未改善骨密度参数。保守治疗时进展不常见。由于只有少数患者进展为PHPT,除了手术成功率较低外,我们建议对大多数NHPT患者进行保守治疗,除非确定有进展的危险因素。